Viridian Therapeutics, Inc. (VRDN) has 20 détenteurs institutionnels et initiés connus enregistrés. Le plus grand détenteur est Logos Global Master Fund LP avec 6,000,000 actions. Parmi les autres détenteurs notables Fairmount Funds Management LLC et Atlas Venture Fund VII L P.
Au cours des 12 derniers mois, les initiés ont effectué 25 transactions sur VRDN l'action — 12 achats (d'une valeur de $11.82M) et 1 ventes (d'une valeur de $70.8K). Les achats d'initiés ont dépassé les ventes durant cette période, ce qui peut signaler une confiance dans les perspectives de l'entreprise.
VRDN Participations des Initiés
Principal Actionnaire
Logos Global Master Fund LP
6,000,000 actions
Achats (12 mois)
12
$11.82M valeur
Ventes (12 mois)
1
$70.8K valeur
Activité de transactions (12 mois)
Principaux actionnaires initiés
| # |
Nom |
Rôle |
Actions détenues |
Dernière déclaration |
Taille relative |
| 1 |
Logos Global Master Fund Lp |
10 Percent Owner |
6,000,000 |
2020-11-16 |
|
| 2 |
Fairmount Funds Management Llc |
10 Percent Owner |
3,914,458 |
2025-10-27 |
|
| 3 |
Atlas Venture Fund Vii L P |
10 Percent Owner |
3,142,580 |
2017-02-13 |
|
| 4 |
Remeditex Ventures Llc |
10 Percent Owner |
2,706,563 |
2017-02-13 |
|
| 5 |
Frazier Life Sciences Public Fund, L.p. |
10 Percent Owner |
1,505,200 |
2021-09-28 |
|
| 6 |
Fairmount Healthcare Fund Ii L.p. |
Director |
1,363,764 |
2022-08-19 |
|
| 7 |
Marshall William Stuart |
President & CEO |
464,000 |
2020-02-14 |
|
| 8 |
Point72 Asset Management, L.p. |
10 Percent Owner |
426,162 |
2020-11-20 |
|
| 9 |
Ra Capital Management, L.p. |
10 Percent Owner |
410,686 |
2020-12-17 |
|
| 10 |
Leverone Jason A. |
Chief Financial Officer |
311,785 |
2021-01-20 |
|
| 11 |
Escolar Diana |
Chief Medical Officer |
270,000 |
2020-02-14 |
|
| 12 |
Myers Scott Dunseth |
Chief Executive Officer |
259,500 |
2023-04-12 |
|
| 13 |
Violin Jonathan |
Chief Executive Officer |
239,205 |
2023-02-07 |
|
| 14 |
Riccitelli Samuel D |
President & CEO |
200,000 |
2016-05-19 |
|
| 15 |
Katz Barrett |
Chief Medical Officer |
108,000 |
2023-02-10 |
|
| 16 |
Humer Kristian |
CFO and Cbo |
108,000 |
2023-02-10 |
|
| 17 |
Rubin Paul D |
EVP, Research & Development |
87,000 |
2019-02-08 |
|
| 18 |
Levy Adam Scott |
Chief Business Officer |
74,000 |
2019-02-08 |
|
| 19 |
Melvin Carrie |
COO |
54,000 |
2023-02-10 |
|
| 20 |
Ciulla Thomas |
Chief Medical Officer |
50,000 |
2024-02-07 |
|
Transactions récentes (12 derniers mois)
| Date |
Nom |
Rôle |
Type |
Actions |
Prix |
Valeur |
| 2026-03-03 |
Tousignant Jennifer |
Chief Legal Officer |
Retenue Fiscale RSU |
1,675 |
$30.19 |
$50.57K |
| 2026-03-03 |
Harmon Seth |
Chief Financial Officer |
Retenue Fiscale RSU |
2,031 |
$30.19 |
$61.32K |
| 2026-03-03 |
Mahoney Stephen F. |
President and CEO |
Retenue Fiscale RSU |
7,408 |
$30.19 |
$223.65K |
| 2026-03-03 |
Beetham Thomas W. |
Chief Operating Officer |
Retenue Fiscale RSU |
3,048 |
$30.19 |
$92.02K |
| 2026-03-03 |
Tousignant Jennifer |
Chief Legal Officer |
Retenue Fiscale RSU |
1,724 |
$29.32 |
$50.55K |
| 2026-03-02 |
Tousignant Jennifer |
Chief Legal Officer |
Attribution de RSU |
23,850 |
- |
- |
| 2025-03-03 |
Tousignant Jennifer |
Officer |
Inconnu |
- |
- |
- |
| 2026-03-03 |
Harmon Seth |
Chief Financial Officer |
Retenue Fiscale RSU |
2,091 |
$29.32 |
$61.31K |
| 2026-03-02 |
Harmon Seth |
Chief Financial Officer |
Attribution de RSU |
20,550 |
- |
- |
| 2025-03-03 |
Harmon Seth |
Officer |
Inconnu |
- |
- |
- |
| 2026-03-02 |
Tripuraneni Radhika |
Chief Medical Officer |
Attribution de RSU |
19,150 |
- |
- |
| 2026-03-03 |
Mahoney Stephen F. |
President and CEO |
Retenue Fiscale RSU |
7,627 |
$29.32 |
$223.62K |
| 2026-03-02 |
Mahoney Stephen F. |
President and CEO |
Attribution de RSU |
111,900 |
- |
- |
| 2026-03-03 |
Beetham Thomas W. |
Chief Operating Officer |
Retenue Fiscale RSU |
3,138 |
$29.32 |
$92.01K |
| 2026-03-02 |
Beetham Thomas W. |
Chief Operating Officer |
Attribution de RSU |
35,300 |
- |
- |
| 2025-12-31 |
Tousignant Jennifer |
Chief Legal Officer |
Vente Informative |
2,272 |
$31.16 |
$70.8K |
| 2025-10-23 |
Fairmount Funds Management Llc |
10 Percent Owner |
Achat Informatif |
454,545 |
$22.00 |
$10M |
| 2025-07-01 |
Gheuens Sarah |
Director |
Attribution de RSU |
21,000 |
$14.47 |
$303.87K |
| 2025-07-01 |
Kiselak Tomas |
Director |
Attribution de RSU |
21,000 |
$14.47 |
$303.87K |
| 2025-07-01 |
Cain Christopher W. |
Director |
Attribution de RSU |
21,000 |
$14.47 |
$303.87K |
| 2025-07-01 |
Moses Jennifer K. |
Director |
Attribution de RSU |
21,000 |
$14.47 |
$303.87K |
| 2025-07-01 |
Ajer Jeffrey Robert |
Director |
Attribution de RSU |
21,000 |
$14.47 |
$303.87K |
| 2025-07-01 |
Morris Arlene |
Director |
Attribution de RSU |
21,000 |
$14.47 |
$303.87K |
| 2025-06-10 |
Fairmount Funds Management Llc |
10 Percent Owner |
Exercice d'Options (Vente) |
12,500 |
$12.31 |
$153.88K |
| 2025-06-09 |
Fairmount Funds Management Llc |
10 Percent Owner |
Exercice d'Options (Vente) |
1,600 |
$7.80 |
$12.48K |
Les autres consultent aussi
